Related Experiment Videos
Calcineurin immunoreactivity in striatonigral degeneration
S Goto1, A Hirano, R R Rojas-Corona
1Division of Neuropathology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467.
Acta Neuropathologica
|January 1, 1989
Summary
Calcineurin (CaN) staining revealed significant neuron and nerve fiber loss in the basal ganglia of Parkinson's disease patients with striatonigral degeneration. This technique aids in assessing striatal efferents and neuropathology.
Area of Science:
- Neuroscience
- Neuropathology
- Immunohistochemistry
Background:
- Striatonigral degeneration is a neuropathological condition associated with Parkinson's disease.
- The basal ganglia, including the substantia nigra, are crucial for motor control.
- Calcineurin (CaN) is a key protein in neuronal function.
Purpose of the Study:
- To investigate the distribution of calcineurin (CaN)-immunoreactive neurons and afferent fibers in the basal ganglia of patients with striatonigral degeneration.
- To evaluate the utility of CaN-immunostaining for assessing striatal efferents and neuropathological changes.
Main Methods:
- Immunohistochemical study of basal ganglia tissue from two patients with striatonigral degeneration and Parkinson's disease.
- Utilized a purified antibody specific to calcineurin (CaN).
Main Results:
- Marked loss of CaN-immunoreactive neurons observed in the putamen and substantia nigra.
- Depletion of CaN-immunoreactive afferent nerve fibers noted in the globus pallidus and substantia nigra.
- CaN immunostaining effectively revealed neuropathological changes not discernible with prior methods.
Conclusions:
- Calcineurin (CaN) immunostaining is a valuable tool for assessing striatal efferents in human basal ganglia.
- The study highlights significant neuropathological alterations in the basal ganglia associated with striatonigral degeneration, particularly involving CaN-expressing neurons and fibers.